CompaniesAffinivax

Affinivax

defunct
About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (3)
View all

Total Trials

3

As Lead Sponsor

2

As Collaborator

1

Total Enrollment

831

By Phase

PHASE1: 2PHASE1/PHASE2: 1

By Status

COMPLETED: 3
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2018
2019
2020
2021
2022
2023
Today
NCT03803202
NCT04525599
Hover over trial bars to see details

Recent Trials

NCT04525599Lead Sponsor
A Study to Assess the Safety, Tolerability and Immunogenicity of ASP3772, a Pneumococcal Vaccine, in Toddlers 12 to 15 Months of Age in Comparison to an Active Comparator
PHASE1Completed
75 participants
Started: Sep 22, 2020 · Completed: Apr 6, 2022
NCT04265911Lead Sponsor
Single Ascending Dose of ASP3772 Study in Japanese Healthy Male and Female Adults, and Single Ascending Dose Study of ASP3772 in Comparison With PPSV23 in Japanese Elderly Male and Female Subjects
PHASE1Completed
126 participants
Started: Feb 19, 2020 · Completed: Nov 7, 2020
NCT03803202Collaborator
A Single Ascending Dose Study in Adults (Stage 1) and Single Ascending Dose-Finding Study (Stage 2) in Elderly Subjects With ASP3772, A Pneumococcal Vaccine
PHASE1/PHASE2Completed
630 participants
Started: Jan 24, 2019 · Completed: Sep 28, 2020
Funding History (2)
D
Jan 13, 2021
Filing
D
Jan 5, 2018
Filing
Related Companies
Gsk
acquired